Timothy Reilly, PhD
About Timothy Reilly, PhD
Tim Reilly is the Chief Development Officer with a background in pharmaceutical sciences, having previously held significant roles at Bristol Myers Squibb and contributed to over 150 clinical stage molecules.
Tim Reilly Chief Development Officer
Tim Reilly currently holds the position of Chief Development Officer. In this role, he is responsible for overseeing the development strategies and initiatives within his organization. His extensive background and experience in the pharmaceutical and biotechnology sectors support his effectiveness in this leadership role.
Tim Reilly Bristol Myers Squibb Experience
Tim Reilly worked at Bristol Myers Squibb for 18 years, where he held various positions of increasing leadership responsibility. Most recently, he served as Senior Vice President of Early Development Program Leadership. During his tenure, he contributed to the development of over 150 clinical stage molecules, showcasing his significant impact on the company's research and development efforts.
Tim Reilly Education and Expertise
Tim Reilly obtained his undergraduate degree from the University of Notre Dame and earned a Ph.D. in pharmaceutical sciences from Wayne State University. He further enhanced his expertise through postdoctoral training in toxicology and cellular/molecular immunology at the National Institutes of Health under the mentorship of Dr. Lance Pohl. Reilly was also a long-standing board-certified Diplomat of the American Board of Toxicology.
Tim Reilly Contributions and Leadership
Tim Reilly has made significant contributions to various organizations and research initiatives. He serves as an industry representative to the Network Steering Committee of the Experimental Cancer Medicines Centres established by Cancer Research UK. Additionally, he is on the Scientific Advisory Panel of the Melanoma Research Foundation and the External Advisory Panel for the Purdue University Institute for Drug Discovery. Reilly also participates in the Translation Research Council for CureSMA and is a co-founder and Chief Scientific Officer of the Spinal Muscular Atrophy Research Team (SMART).